Ignite Creation Date:
2025-12-24 @ 9:23 PM
Ignite Modification Date:
2026-02-11 @ 7:16 AM
Study NCT ID:
NCT00914732
Status:
COMPLETED
Last Update Posted:
2021-02-03
First Post:
2009-06-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lyophilized IMVAMUNE® (1x10^8 TCID50) Versus Liquid IMVAMUNE® (1x10^8 TCID50) Administered Subcutaneously and a Lower Dose Liquid IMVAMUNE® (2x10^7 TCID50) Administered Intradermally
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization: